Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System
Authors:
- 12 October 2009
- journal article
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 12 (4) , 317-324
Abstract
(2009). Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System. Journal of Medical Economics: Vol. 12, No. 4, pp. 317-324.Keywords
This publication has 15 references indexed in Scilit:
- Antipsychotic Medication Adherence in SchizophreniaPsychiatric Clinics of North America, 2007
- A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2006
- Effectiveness of Community Treatment Orders for Treatment of Schizophrenia with Oral or Depot Antipsychotic Medication: Clinical OutcomesAustralian & New Zealand Journal of Psychiatry, 2006
- Pharmacoeconomics of long-acting risperidone: Results and validity of cost-effectiveness modelsPharmacoEconomics, 2005
- Modelling the impact of compliance on the costs and effects of long-acting risperidone in CanadaPharmacoEconomics, 2005
- Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USAPharmacoEconomics, 2005
- Early Clinical Experience With Risperidone Long-Acting InjectionThe Journal of Clinical Psychiatry, 2004
- Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With SchizophreniaPsychiatric Services, 2004
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical AntipsychoticAmerican Journal of Psychiatry, 2003